Efficacy and safety of nitazoxanide and escitalopram as adjuvant therapies in patients with rheumatoid arthritis: a randomized controlled study
Nitazoxanide and escitalopram could serve as potential adjuvant therapies for patients with RA based on their effectiveness and safety data.
Authors
- Dalia El‐Afify (ORCID: https://orcid.org/0000-0002-1454-4637)
- Abdel Moaty A. Afifi (ORCID: https://orcid.org/0000-0002-4132-3530)
- Tarek M. Mostafa (ORCID: https://orcid.org/0000-0003-1071-5416)
- Abeer A. Elsayed (ORCID: https://orcid.org/0000-0002-6787-2087)
Institutions
- Sinai University (EG)
- Mansoura University (EG)
- Tanta University (EG)
- Arish University (EG)
Publication Details
- Journal
- European Journal of Clinical Pharmacology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1007/s00228-025-03911-w
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Technology Development Fund
- Mansoura University